Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection

Virology

Volumn 430, Issue 2, 2012, Pages 127-135

  Quan, Fu Shi ^a   Kim, Min Chul ^b   Lee, Byeong Jae ^b,e   Song, Jae Min ^c   Compans, Richard W ^b   Kang, Sang Moo ^d  

^a Kyung Hee University Hospital   (South Korea)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sungshin Women's University   (South Korea)

^d GEORGIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Influenza; Neuraminidase; Protection; Virus like particles

Indexed keywords

CLODRONIC ACID; LIPOSOME; PROTEIN M1; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; DRUG ANTIGENICITY; ENZYME INHIBITION; FEMALE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS LIKE AGENT; VIRUS STRAIN; WEIGHT REDUCTION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; CROSS PROTECTION; IMMUNE SERA; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84862215230     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.05.006     Document Type: Article

References (60)

1. Bosio C.M., Dow S.W. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 2005, 175(10):6792-6801.
2. Brett I.C., Johansson B.E. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 2005, 339(2):273-280.
3. Bright R.A., Carter D.M., Crevar C.J., Toapanta F.R., Steckbeck J.D., Cole K.S., Kumar N.M., Pushko P., Smith G., Tumpey T.M., Ross T.M. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008, 3(1):e1501.
4. Bright R.A., Carter D.M., Daniluk S., Toapanta F.R., Ahmad A., Gavrilov V., Massare M., Pushko P., Mytle N., Rowe T., Smith G., Ross T.M. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007, 25(19):3871-3878.
5. Cate T.R., Rayford Y., Nino D., Winokur P., Brady R., Belshe R., Chen W., Atmar R.L., Couch R.B. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine 2010, 28(9):2076-2079.
6. Chen J., Fang F., Li X., Chang H., Chen Z. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 2005, 23(34):4322-4328.
7. Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Matsuo K., Kurata T., Tamura S. Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 2000, 18(28):3214-3222.
8. Chen Z., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., Aizawa C., Kurata T., Tamura S. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 1999, 17(7-8):653-659.
9. Chen Z., Sahashi Y., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., Aizawa C., Kurata T., Tamura S. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 1998, 16(16):1544-1549.
10. Compans R.W., Dimmock N.J., Meier-Ewert H. Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus. J. Virol. 1969, 4(4):528-534.
11. Couch R.B. Seasonal inactivated influenza virus vaccines. Vaccine 2008, 26(Suppl 4):D5-D9.
12. Couch R.B., Kasel J.A., Gerin J.L., Schulman J.L., Kilbourne E.D. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J. Infect. Dis. 1974, 129(4):411-420.
13. Deroo T., Jou W.M., Fiers W. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 1996, 14(6):561-569.
14. Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., Osterhaus A.D. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 2005, 79(5):2814-2822.
15. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., Robbins P.D., Swayne D.E., Donis R.O., Katz J.M., Barratt-Boyes S.M., Gambotto A. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 2006, 80(4):1959-1964.
16. Johansson B.E. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 1999, 17(15-16):2073-2080.
17. Johansson B.E., Brett I.C. Changing perspective on immunization against influenza. Vaccine 2007, 25(16):3062-3065.
18. Johansson B.E., Bucher D.J., Kilbourne E.D. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 1989, 63(3):1239-1246.
19. Johansson B.E., Kilbourne E.D. Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. J. Virol. 1993, 67(10):5721-5723.
20. Johansson B.E., Matthews J.T., Kilbourne E.D. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 1998, 16(9-10):1009-1015.
21. Johansson B.E., Moran T.M., Kilbourne E.D. Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proc. Natl. Acad. Sci. USA 1987, 84(19):6869-6873.
22. Kang S.M., Quan F.S., Huang C., Guo L., Ye L., Yang C., Compans R.W. Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies. Virology 2005, 331(1):20-32.
23. Kang S.M., Song J.M., Quan F.S., Compans R.W. Influenza vaccines based on virus-like particles. Virus research 2009, 143(2):140-146.
24. Kang S.M., Yoo D.G., Kim M.C., Song J.M., Park M.K.,.O.,.E., Quan F.S., Akira S., Compans R.W. MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination. J. Virol. 2011, 85(21):11391-11400.
25. Kang S.M., Yoo D.G., Lipatov A.S., Song J.M., Davis C.T., Quan F.S., Chen L.M., Donis R.O., Compans R.W. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS ONE 2009, 4(3):e4667.
26. Kasel J.A., Couch R.B., Gerin J.L., Schulman J.L. Effect of influenza anti-neuraminidase antibody on virus neutralization. Infect. Immun. 1973, 8(1):130-131.
27. Kilbourne E.D., Johansson B.E., Grajower B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc. Natl. Acad. Sci. USA 1990, 87(2):786-790.
28. Kim Y.C., Quan F.S., Yoo D.G., Compans R.W., Kang S.M., Prausnitz M.R. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J. Infect. Dis. 2010, 201(2):190-198.
29. Li X., Fang F., Song Y., Yan H., Chang H., Sun S., Chen Z. Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection. DNA Cell Biol. 2006, 25(4):197-205.
30. Martinet W., Saelens X., Deroo T., Neirynck S., Contreras R., Min Jou W., Fiers W. Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur. J. Biochem. 1997, 247(1):332-338.
31. McGill J., Van Rooijen N., Legge K.L. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J. Exp. Med. 2008, 205(7):1635-1646.
32. Mongini P.K., Paul W.E., Metcalf E.S. T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch. J. Exp. Med. 1982, 155(3):884-902.
33. Murphy B.R., Kasel J.A., Chanock R.M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N. Engl. J. Med. 1972, 286(25):1329-1332.
34. Novak M., Moldoveanu Z., Schafer D.P., Mestecky J., Compans R.W. Murine model for evaluation of protective immunity to influenza virus. Vaccine 1993, 11(1):55-60.
35. Pavlova S.P., Veits J., Keil G.M., Mettenleiter T.C., Fuchs W. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine 2009, 27(5):773-785.
36. Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 2004, 199:227-250.
37. Pushko P., Tumpey T.M., Van Hoeven N., Belser J.A., Robinson R., Nathan M., Smith G., Wright D.C., Bright R.A. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007, 25(21):4283-4290.
38. Qiao C.L., Yu K.Z., Jiang Y.P., Jia Y.Q., Tian G.B., Liu M., Deng G.H., Wang X.R., Meng Q.W., Tang X.Y. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian. Pathol. 2003, 32(1):25-32.
39. Qiu M., Fang F., Chen Y., Wang H., Chen Q., Chang H., Wang F., Wang H., Zhang R., Chen Z. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Biochem. Biophys. Res. Commun. 2006, 343(4):1124-1131.
40. Quan F.S., Compans R.W., Nguyen H.H., Kang S.M. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J. Virol. 2008, 82(3):1350-1359.
41. Quan F.S., Huang C., Compans R.W., Kang S.M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 2007, 81(7):3514-3524.
42. Quan F.S., Kim Y.C., Compans R.W., Prausnitz M.R., Kang S.M. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J. Control Release. 2010.
43. Quan F.S., Kim Y.C., Vunnava A., Yoo D.G., Song J.M., Prausnitz M.R., Compans R.W., Kang S.M. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J. Virol. 2010, 84(15):7760-7769.
44. Quan F.S., Kim Y.C., Yoo D.G., Compans R.W., Prausnitz M.R., Kang S.M. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One 2009, 4(9):e7152.
45. Quan F.S., Steinhauer D., Huang C., Ross T.M., Compans R.W., Kang S.M. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine 2008, 26(26):3352-3361.
46. Quan F.S., Vunnava A., Compans R.W., Kang S.M. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One 2010, 5(2):e9161.
47. Quan F.S., Yoo D.G., Song J.M., Clements J.D., Compans R.W., Kang S.M. Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J. Virol. 2009, 83(9):4489-4497.
48. Sandbulte M.R., Jimenez G.S., Boon A.C., Smith L.R., Treanor J.J., Webby R.J. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007, 4(2):e59.
49. Schulman J.L., Khakpour M., Kilbourne E.D. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J. Virol. 1968, 2(8):778-786.
50. Sha Z., Compans R.W. Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J. Virol. 2000, 74(11):4999-5005.
51. Song J.M., Hossain J., Yoo D.G., Lipatov A.S., Davis C.T., Quan F.S., Chen L.M., Hogan R.J., Donis R.O., Compans R.W., Kang S.M. Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology 2010, 405(1):165-175.
52. Song J.M., Van Rooijen N., Bozja J., Compans R.W., Kang S.M. Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc. Natl. Acad. Sci. USA 2011, 108(2):757-761.
53. Song J.M., Wang B.Z., Park K.M., Van Rooijen N., Quan F.S., Kim M.C., Jin H.T., Pekosz A., Compans R.W., Kang S.M. Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS One 2011, 6(1):e14538.
54. Sylte M.J., Hubby B., Suarez D.L. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 2007, 25(19):3763-3772.
55. Thepen T., McMenamin C., Oliver J., Kraal G., Holt P.G. Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur J Immunol 1991, 21(11):2845-2850.
56. Van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Meth. 1994, 174(1-2):83-93.
57. Webster R.G., Laver W.G., Kilbourne E.D. Reactions of antibodies with surface antigens of influenza virus. J. Gen. Virol. 1968, 3(3):315-326.
58. Webster R.G., Reay P.A., Laver W.G. Protection against lethal influenza with neuraminidase. Virology 1988, 164(1):230-237.
59. Wiesener N., Schutze T., Lapp S., Lehmann M., Jarasch-Althof N., Wutzler P., Henke A. Analysis of different DNA vaccines for protection of experimental influenza A virus infection. Viral Immunol. 2011, 24(4):321-330.
60. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 1990, 8:737-771.